115 related articles for article (PubMed ID: 37580210)
1. Cost-effectiveness of cytomegalovirus vaccination for females in China: A decision-analytical Markov study.
Yin MZ; Gu YY; Shu JT; Zhang B; Su M; Zhang LP; Jiang YH; Qin G
Vaccine; 2023 Sep; 41(40):5825-5833. PubMed ID: 37580210
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus.
Dempsey AF; Pangborn HM; Prosser LA
Vaccine; 2012 Jun; 30(27):4060-6. PubMed ID: 22525796
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France.
N'Diaye DS; Launay O; Picone O; Tsatsaris V; Azria E; Rozenberg F; Schwarzinger M; Yazdanpanah Y
Vaccine; 2018 Feb; 36(10):1285-1296. PubMed ID: 29397227
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
Patel HD; Roberts ET; Constenla DO
Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
Armstrong EP
J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
[TBL] [Abstract][Full Text] [Related]
7. Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection.
Lanzieri TM; Bialek SR; Ortega-Sanchez IR; Gambhir M
Vaccine; 2014 Jun; 32(30):3780-6. PubMed ID: 24837782
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of vaccinating children in Malawi with RTS,S vaccines in comparison with long-lasting insecticide-treated nets.
Seo MK; Baker P; Ngo KN
Malar J; 2014 Feb; 13():66. PubMed ID: 24564883
[TBL] [Abstract][Full Text] [Related]
9. Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China.
Xia R; Sun S; Shen M; Zhang L; Zhuang G
Vaccine; 2019 Sep; 37(39):5868-5876. PubMed ID: 31443991
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of hepatitis B vaccine booster in children born to HBsAg-positive mothers in rural China.
Wang Y; Shi JF; Wang L; Yan Y; Yao H; Dai M; Chen T; Qu C
Int J Infect Dis; 2019 Jan; 78():130-139. PubMed ID: 30466898
[TBL] [Abstract][Full Text] [Related]
11. The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America.
Lee BY; Bacon KM; Connor DL; Willig AM; Bailey RR
PLoS Negl Trop Dis; 2010 Dec; 4(12):e916. PubMed ID: 21179503
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of hepatitis A vaccination in Indonesia.
Suwantika AA; Beutels P; Postma MJ
Hum Vaccin Immunother; 2014; 10(8):2342-9. PubMed ID: 25424941
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of introducing rotavirus vaccine into immunization program in Zhejiang province, China: A decision tree-Markov model study.
Lv H; Chen F; Wang Y; Chen Y; Hu Y
Hum Vaccin Immunother; 2023 Aug; 19(2):2217075. PubMed ID: 37455405
[TBL] [Abstract][Full Text] [Related]
14. The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis.
Yin J; Ji Z; Liang P; Wu Q; Cui F; Wang F; Liang X; Zhuang G
Vaccine; 2015 Jul; 33(31):3731-8. PubMed ID: 26057138
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia.
Sundaram N; Chen C; Yoong J; Luvsan ME; Fox K; Sarankhuu A; La Vincente S; Jit M
Vaccine; 2017 Feb; 35(7):1055-1063. PubMed ID: 28109706
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of the Haemophilus influenzae type b vaccine for infants in mainland China.
Ning G; Yin Z; Li Y; Wang H; Yang W
Hum Vaccin Immunother; 2018 Jan; 14(1):36-44. PubMed ID: 29049002
[TBL] [Abstract][Full Text] [Related]
17. Estimated Cost-effectiveness of Newborn Screening for Congenital Cytomegalovirus Infection in China Using a Markov Model.
Chen K; Zhong Y; Gu Y; Sharma R; Li M; Zhou J; Wu Y; Gao Y; Qin G
JAMA Netw Open; 2020 Dec; 3(12):e2023949. PubMed ID: 33275150
[TBL] [Abstract][Full Text] [Related]
18. Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan Africa.
Kim JJ; Campos NG; O'Shea M; Diaz M; Mutyaba I
Vaccine; 2013 Dec; 31 Suppl 5():F60-72. PubMed ID: 24331749
[TBL] [Abstract][Full Text] [Related]
19. Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis.
Zou Z; Fairley CK; Ong JJ; Hocking J; Canfell K; Ma X; Chow EPF; Xu X; Zhang L; Zhuang G
Lancet Glob Health; 2020 Oct; 8(10):e1335-e1344. PubMed ID: 32971056
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of rotavirus vaccination in children under five years of age in 195 countries: A meta-regression analysis.
Janko MM; Joffe J; Michael D; Earl L; Rosettie KL; Sparks GW; Albertson SB; Compton K; Pedroza Velandia P; Stafford L; Zheng P; Aravkin A; Kyu HH; Murray CJL; Weaver MR
Vaccine; 2022 Jun; 40(28):3903-3917. PubMed ID: 35643565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
